XML 45 R29.htm IDEA: XBRL DOCUMENT
v3.23.3

Segment Information (Tables) | 3 Months Ended
--- | ---
Sep. 30, 2023
Segment Reporting, Revenue Reconciling Item [Line Items] |
Revenue from External Customers by Geographic Areas [Table Text Block] | The following table presents revenue by geographic area:
| Three Months Ended September 30,
(in millions) | 2023 |  | 2022
United States | $ | 53,557 |  |  | $ | 48,477 |
International | 1,209 |  |  | 1,129 |
Total segment revenue | 54,766 |  |  | 49,606 |
Corporate (1) | (3) |  |  | (3) |
Total revenue | $ | 54,763 |  |  | $ | 49,603 |
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Schedule of Segment Reporting Information, by Segment [Table Text Block] | Revenue The following table presents revenue for each reportable segment, disaggregated revenue within our two reportable segments and Corporate:
| Three Months Ended September 30,
(in millions) | 2023 |  | 2022
Pharmaceutical and Specialty Pharmaceutical Distribution and Services (1) | $ | 50,682 |  |  | $ | 45,547 |
Nuclear and Precision Health Solutions | 324 |  |  | 281 |
Pharmaceutical segment revenue | 51,006 |  |  | 45,828 |
Medical Products and Distribution (2) | 3,076 |  |  | 3,140 |
Cardinal Health at-Home Solutions | 684 |  |  | 638 |
Medical segment revenue | 3,760 |  |  | 3,778 |
Total segment revenue | 54,766 |  |  | 49,606 |
Corporate (3) | (3) |  |  | (3) |
Total revenue | $ | 54,763 |  |  | $ | 49,603 |
(1)Comprised of all Pharmaceutical segment businesses except for Nuclear and Precision Health Solutions division. (2)Comprised of all Medical segment businesses except for Cardinal Health at-Home Solutions division. (3)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment | The following table presents segment profit by reportable segment and Corporate:
| Three Months Ended September 30,
(in millions) | 2023 |  | 2022
Pharmaceutical | $ | 507 |  |  | $ | 431 |
Medical | 71 |  |  | (8) |
Total segment profit | 578 |  |  | 423 |
Corporate | (592) |  |  | (286) |
Total operating earnings/(loss) | $ | (14) |  |  | $ | 137 |
Assets by Reportable Segment | The following table presents total assets for each reportable segment and Corporate at:
(in millions) | September 30, 2023 |  | June 30, 2023
Pharmaceutical | $ | 28,968 |  |  | $ | 28,077 |
Medical | 9,425 |  |  | 10,130 |
Corporate | 5,317 |  |  | 5,210 |
Total assets | $ | 43,710 |  |  | $ | 43,417 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph a -SubTopic 10 -Topic 280 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingRevenueReconcilingItemLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration